【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemophilia Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.2. Rising neonatal population driving diagnostic rate
3.7.3. Favorable government initiatives
3.7.4. Rising R & D and new product development
3.7.5. Rising adoption for prophylaxis treatment
3.7.6. Market Restraint Analysis
3.7.7. High cost of treatment
3.7.8. Industry Challenges
3.7.9. Low adoption rate to advanced technologies
3.8. Hemophilia: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (Low)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (Moderate)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
Chapter 4. Hemophilia Market: Segment Analysis, By Type, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Type market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Hemophilia Market, by Type, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Hemophilia A
4.5.2. Hemophilia B
4.5.3. Hemophilia C
4.5.4. Others
Chapter 5. Hemophilia Market: Segment Analysis, By Treatment, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Type market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Hemophilia Market, by Treatment, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Replacement therapy
5.5.2. ITI therapy
5.5.3. Gene therapy
Chapter 6. Hemophilia Market: Segment Analysis, By Therapy, 2015 – 2026 (USD Million)
6.1. Definitions & Scope
6.2. Type market share analysis, 2018 & 2026
6.3. Segment Dashboard
6.4. Global Hemophilia Market, by Therapy, 2015 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
6.5.1. On-demand
6.5.2. Prophylaxis
Chapter 7. Hemophilia Market: Regional Market Analysis, 2015 – 2026 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2018 & 2026
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2018
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
7.8. North America
7.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.8.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.8.5. U.S.
7.8.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.8.6. Canada
7.8.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9. Europe
7.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.9.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.5. Germany
7.9.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.6. UK
7.9.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.7. France
7.9.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.8. Italy
7.9.8.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.8.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.8.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.9. Spain
7.9.9.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.9.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.9.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10. Asia Pacific
7.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.10.1.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.1.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.1.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.2. China
7.10.2.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.2.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.2.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.3. Japan
7.10.3.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.3.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.3.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.4. India
7.10.4.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.4.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.4.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.5. Thailand
7.10.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.6. South Korea
7.10.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11. Latin America
7.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.11.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.5. Brazil
7.11.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.6. Mexico
7.11.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.7. Argentina
7.11.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.8. Columbia
7.11.8.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.8.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.8.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12. Middle East and Africa
7.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.12.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.5. South Africa
7.12.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.6. Saudi Arabia
7.12.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.7. UAE
7.12.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
Chapter 8. Hemophilia Market – Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2018
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company Market Share/Ranking, by region
8.4.3. Competitive Dashboard Analysis
8.4.3.1. Market Differentiators
8.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
8.5. Private Companies
8.5.1. List of key emerging companies’ /technology disruptors/innovators
8.5.2. Funding Outlook (Optional)
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.6. Supplier Ranking
8.7. Key companies profiled
8.7.1. Novo Nordisk
8.7.1.1. Company Overview
8.7.1.2. Financial Performance
8.7.1.3. Product Benchmarking
8.7.1.4. Strategic Initiatives
8.7.2. Biogen.
8.7.2.1. Company Overview
8.7.2.2. Financial Performance
8.7.2.3. Product Benchmarking
8.7.2.4. Strategic Initiatives
8.7.3. Chugai Pharmaceutical
8.7.3.1. Company Overview
8.7.3.2. Financial Performance
8.7.3.3. Product Benchmarking
8.7.3.4. Strategic Initiatives
8.7.4. Bayer Healthcare
8.7.4.1. Company Overview
8.7.4.2. Financial Performance
8.7.4.3. Product Benchmarking
8.7.4.4. Strategic Initiatives
8.7.5. Pfizer.
8.7.5.1. Company Overview
8.7.5.2. Financial Performance
8.7.5.3. Product Benchmarking
8.7.5.4. Strategic Initiatives
8.7.6. Shire Plc
8.7.6.1. Company Overview
8.7.6.2. Financial Performance
8.7.6.3. Product Benchmarking
8.7.6.4. Strategic Initiatives
8.7.7. Baxalta (Baxter Healthcare)
8.7.7.1. Company Overview
8.7.7.2. Financial Performance
8.7.7.3. Product Benchmarking
8.7.7.4. Strategic Initiatives
8.7.8. CSL Behring.
8.7.8.1. Company Overview
8.7.8.2. Financial Performance
8.7.8.3. Product Benchmarking
8.7.8.4. Strategic Initiatives
8.7.9. Octapharma.
8.7.9.1. Company Overview
8.7.9.2. Financial Performance
8.7.9.3. Product Benchmarking
8.7.9.4. Strategic Initiatives
Chapter 9. KOL Commentary
Chapter 10. Recommendations
【レポート販売概要】
■ タイトル：血友病の世界市場：タイプ別（血友病A、血友病B、血友病C）、治療別（オンデマンド療法、予防投与）、治療別（補充療法、遺伝子治療）、セグメント予測■ 英文：Hemophilia Market Analysis by Type (Hemophilia A, Hemophilia B, Hemophilia C), by Treatment (On-demand, Prophylaxis), by Therapy (Replacement Therapy, Gene Therapy), And Segment Forecasts, 2019 - 2026
■ 発行日：2019年2月25日
■ 調査会社：Grand View Research
■ 商品コード：GVW903090
■ 調査対象地域：グローバル
- 二酸化チタンの世界市場予測Titanium dioxide 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about titanium dioxide market in the all-in-one report issued in a logical and easily accessible format. In addition to the analyti …
- 世界の鉄道産業におけるIT支出市場About Information Technology Spending in Railways Railway infrastructure plays a vital role in the economic and social development of a country. Globally, the traffic congestion on roads has increased. As a result, people choose trains as a mode of transportation as it is a more feasible and convenient option, especially for long-distance traveling. The rise in passenger and freight traffic has le …
- ワイヤレス充電器の世界市場2016-2020About Wireless Chargers Wireless chargers are part of a wireless charging system that consists of a transmitter and a receiver. The receiver is attached to the device, which has to be charged, while the transmitter is part of the wireless charger connected to the main supply or power source. Technavio’s analysts forecast the global wireless chargers market to grow at a CAGR of 33.14% during the pe …
- 呼吸器合胞体ウイルス（RSV）感染症(Respiratory Syncytial Virus Infections)：世界の治験レビュー2014年下半期版Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014" provides data on the Respiratory Syncytial Virus (RSV) Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Respir …
- ヘテロジニアスネットワークの世界市場：スモールセル、DAS（分散アンテナシステム）、C-RAN（無線アクセスネットワーク）、キャリアWiFiThe heterogeneous networks are nothing but the collaboration of Cloud/Centralized RAN topology with various small cells which includes, Pico cell, Femtocell etc. The various technologies collected offer wireless network based services. The heterogeneous network is a very wide industry. In this heterogeneous networks market research report we have considered the major technology deployed in this ma …
- Location-based Services: Solutions and Market OpportunitiesThis report bundle is by far the most comprehensive research covering the market for Location-based Services (LBS) solutions and market opportunities. It covers cellular mobile location determination and related services as well as other location methods such as RFID. It includes research that covers market opportunities, company analysis, solution analysis, emerging opportunities, market vertical …
- 神経根症(Radiculopathy)：世界の治験レビュー（2015年上半期版）Radiculopathy Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H1, 2015" provides data on the Radiculopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Radiculopathy. It includes an overview of the trial numbers and their recruitment status as per the …
- 中国の製薬市場（一般用医薬品市場）動向（～2024）From 2008 to 2013, China’s OTC drugs market reported an average growth of 15% with the market reaching $20.6bn in 2013 up from to $11bn in 2008 - but what will it be this year? Next year? and in 5 years time? The OTC drugs market in China was characterised by a late start, but fast growth, along with huge potential in comparison to that of the mature OTC markets in many western countries. Your com …
- Belviq（肥満治療薬）：市場予測及び分析（～2022）Belviq (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molec …
- 2014年戦略提言：世界の呼吸器病診断検査市場Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,200.This new 366-page report from Venture Planning Group contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About thi …
- アイトラッキングの世界市場2017-2021ABSTRACTAbout Eye Tracking ET technology can be used in the form of a software application or as a hardware device to detect the gaze point of an eye movement. ET devices enable users for hands-free interaction in human-computer interaction processes. ET systems are also implemented to understand human behavior by real-time tracking of eye movements. Technavio’s analysts forecast the global eye tr …
- スマートビルにおけるIoTの世界市場This Smart Building research focuses primarily upon commercial real estate (CRE), such as office buildings and warehouses, which can be augmented with Internet of Things (IoT) technologies for improved communication, automation, and many workplace benefits for both humans and machines. In addition to optimization of tenant operations, CRE owners recognize the ability to realize significantly highe …
- 2014年市場分析：ドイツの肝炎診断Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, …
- スマートポートの世界市場予測（～2024年）“The global smart ports market is projected to grow at a CAGR of 25% from 2019 to 2024” The global smart ports market is projected to reach USD 5.3 billion by 2024 from an estimated USD 1.7 billion in 2019, at a CAGR of 25.0% during the forecast period. This growth can be attributed to factors such as increasing global trade activities, and an urgent need to cut down on redundant & additional expe …
- 包装スクッグの世界市場2018-2022About Packaged Zhug Zhug is a condiment or spice blend of Yemeni origin and is made from fresh green or red-hot peppers seasoned with coriander, salt, garlic, and various spices. Technavio’s analysts forecast the global packaged zhug market to grow at a CAGR of 4.4% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global Pac …
